Regulation of single chain urokinase by small peptides

Thrombosis Research

Volumn 84, Issue 4, 1996, Pages 243-252

  Higazi, Abd Al Roof ^a   Cines, Douglas ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

plasmin; plasminogen; urokinase; urokinase receptor

Indexed keywords

PEPTIDE; SINGLE CHAIN UROKINASE; UNCLASSIFIED DRUG; UROKINASE;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SUBSTRATE; FIBRINOLYSIS; PRIORITY JOURNAL; REGULATORY MECHANISM;

CHROMOGENIC COMPOUNDS; ENZYME ACTIVATION; HUMANS; PEPTIDES; PLASMINOGEN ACTIVATORS; RECEPTORS, CELL SURFACE; URINARY PLASMINOGEN ACTIVATOR;

EID: 0030588694     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(96)00184-3     Document Type: Article

References (25)

1. DANO K., ANDREASON P.A., GRONDAHL-HANSEN J., KRISTENSEN P., NEILSON L.S., SKRIVERS L. Plasminogen activator, tissue degradation and cancer. Adv Cancer Res. 44:1985;139-146.
2. GYETKO M., CHEN G.-H., MCDONALD R.A., GOODMAN R., HUFFNAGEL G.B., WIILKENSEN C.C., FULLER J.A., TOEWS G.B. Urokinase is required for the pulmonary inflammatory response to Cryptococcus neoformans. A murine transgenic model. J. Clin. Invest. 97:1996;1818-1826.
3. PANNELL R., GUREWICH V. Activation of plasminogen by single-chain urokinase or by two-chain urokinase A demonstration that single-chain urokinase has a low catalytic activity (prourokinase). Blood. 69:1987;22-28.
4. KASSI S., ARIMURA H., NISHIDA M., SUYAMA T. Proteolytic cleavage of single chain prourokinase induces conformational change which follows activation of the zymogen and production of its high affinity to fibrin. J. Biol. Chem. 260:1985;12382-12389.
5. OLSON D., POLLANEN J., HOYER-HANSEN G., RONNE E., SAKAGUCHI K., WUN T.-Z., APPELLA E., DANO K., BLASI F. Internalization of the urokinase-type plasminogen activator inhibitor type-1 complex is mediated by the urokinase receptor. J. Biol. Chem. 267:1992;9129-9133.
6. 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Evidence that the urokinase receptor protects pro-urokinase against binding to the endocytic receptor. J. Biol. Chem. 269:1994;25668-25676.
7. HUSAIN S.S. Single-chain urokinase-type plasminogen activator does not possess measurable intrinsic amidolytic or plasminogen activator activities. Biochem. 30:1991;5707-5805.
8. COLLEN D., ZAMARRON C., LIJNEN H.R., HOYLAERTS M. Activation of plasminogen by pro-urokinase. II. Kinetics J. Biol. Chem. 261:1986;1259-1266.
9. NELLES L., LIJNEN H.R., COLLEEN D., HOLMES W.E. Characterization of recombinant human single chain urokinase-type plasminogen activator mutants produced by site-specific mutagenesis of Lys 158. J. Biol. Chem. 262:1987;5682-5689.
10. NYKJAER, A., PETERSEN, C.M., JENSEN, P.H., RASMUSSEN, H., SHUMAN, M.A., COHEN, R.L., and GLIEMANNI, J. The urokinase receptor is a ligand for the cation independent mannose-6-phosphate receptor/insulin-like growth factor II receptor. Fifth international workshop on molecular and cellular biology of plasminogen activation, 40, 1995.(Abstract).
11. LIU J., PANNELL R., GUREWICH V. A transitional state of pro-urokinase that has a higher catalytic efficiency against glu-plasminogen than urokinase. J. Biol. Chem. 267:1992;15289-15292.
12. PETERSEN L.C., LUND L.R., NIELSEN L.S., DANO K., SKRIVER L. One-chain urokinase-type plasminogen activator from human sarcoma cells is a proenzyme with little or no intrinsic activity. J. Biol. Chem. 263:1988;11189-11195.
13. HIGAZI A.A.-R., COHEN R.L., HENKIN J., KNISS D., SCHWARTZ B.S., CINES D.B. Enhancement of the enzymatic activity of single-chain urokinase plasminogen activator by soluble urokinase receptor. J. Biol. Chem. 270:1995;17375-17380.
14. BEHRENDT N., RONNE E., DANO K. The structure and function of the urokinase receptor a membrane protein governing plasminogen activation on the cell surface. Biol. Chem. Hoppe-Seyler. 376:1995;269-279.
15. ELLIS V. Functional analysis of the cellular receptor for urokinase in plasminogen activation. Receptor binding has no influence on the zymogenic nature of pro-urokinase. J. Biol. Chem. 271:1996;14779-14784.
16. MANCHANDA N., SCHWARTZ B.S. Single chain urokinase. Augmentation of enzymatic activity upon binding to monocytes. J. Biol. Chem. 266:1991;14580-14584.
17. HIGAZI A.A.-R., MAZAR A., WANG J., REILLY R., HENKIN J., KNISS D., CINES D. Single chain urokinase-type plasminogen activator bound to its receptor is relatively resistant to plasminogen activator inhibitor type 1. Blood. 87:1996;3545-3549.
18. MARCOTTE P.A., KOZAN I.M., DORWIN S.A., RYNA J.M. The matrix metalloproteinase pump-1 catalyzes the formation of low molecular weight (pro)urokinase in cultures of human kidney cells. J. Biol. Chem. 267:1992;13803-13806.
19. MARCOTTE P.A., DUDLAK D., LESKI M.L., RYAN J., HENKIN J. Characterization of a metalloprotease which cleaves with high specificity the Glu(143)-Leu(144) bond of urokinase. Fibrinolysis. 6(Suppl. 1):1992;57-62.
20. HIGAZI A.A.-R., FINCI-YEHESKEL Z., SAMARA A.A., AZIZA R., MAYER M. Stimulation of plasmin activity by oleic acid. Biochem. J. 282:1992;863-866.
21. BARNATHAN E.S., KUO A., ROSENFELD L., KARIKO K., LESKI M., ROBBIATI F., NOLLI M.L., HENKIN J., CINES D.B. Interaction of single chain urokinase type plasminogen activator with human endothelial cells. J. Biol. Chem. 265:1990;2865-2872.
22. ELLIS V., BEHRENDT N., DANO K. Plasminogen activation by receptor-bound urokinase. J. Biol. Chem. 266:1991;12752-12758.
23. LONGSTAFF C., CLOUGH A.M., GAFFNEY P.J. Kinetics of plasmin activation of single chain urinary-type plasminogen activator (scu-PA) and demonstration of a high affinity interaction between scu-PA and plasminogen. J. Biol. Chem. 267:1992;173-179.
24. APPELLA E., ROBINSON E.A., ULRICH S.J., STOPPELLI M.P., CORTI A., CASSANI G., BLASI F. The receptor binding sequence of urokinase. J. Biol. Chem. 262:1987;4437-4440.
25. HIGAZI A.A.-R., UPSON R., COHEN R., MCCRAE K.R., MANUPPELLO J., BOGNACKI J., HENKIN J., KOUNNAS M., STRICKLAND D., PREISSNER K.T., LAWLER J., CINES D.B. Interaction of single chain urokinase with its receptor induces the appearance and disappearance of binding epitopes within the resultant complex for other cell surface proteins. Blood. 88:1996;542-551.